EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial

Stanley G Rockson, Roman Skoracki

Lymphatic Research and Biology · 01.12.2023 · 21 (6) · 581-584

DOI: 10.1089/lrb.2022.0085 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lymphatic Research and Biology, online erschienen am 22.12.2023. Verfasst von Stanley G Rockson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Cancer Lymphedema, Lymphedema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A recently completed clinical trial compared a novel nonpneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD) for the treatment of breast cancer-related lymphedema (BCRL); the study revealed that the NPCD produced superior clinical and quality-of-life (QOL) outcomes. In this subanalysis, we sought to examine these results within the subset of trial subjects aged ≥65 years.

Methods

A randomized crossover head-to-head trial was conducted to compare the NPCD with a commercially available APCD. Patients were randomly assigned to one or the other device for 28 days of use, followed by a 4-week washout period before a comparable 28-day utilization of the alternate device. Limb edema, adherence to daily device use, and QOL measures were collected at day 0 and 28 of each period.

Results

A total of 14 subjects were aged ≥65. During NPCD use, subjects experienced a mean decrease in limb edema of 100.3% ( p = 0.0082) as well as improvements in mean overall and subscale scores of the Lymphedema Quality of Life Questionnaire (LYMQOL). By comparison, during APCD use limb edema decreased by a mean of 2.9% ( p = 0.8899) with no significant changes in any LYMQOL scores. Mean adherence was significantly higher during NPCD use (96.6%) than during APCD use (58.3%, p < 0.0001).

Conclusions

The novel NPCD produced superior clinical and QOL outcomes in older subjects with BCRL. ClinicalTrials.gov ID: NCT04908254

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBreast Cancer LymphedemaLymphedemaHumansAgedFemaleQuality of LifeCross-Over StudiesEdemaTreatment Outcome

Stichwörter der Autor:innen

breast cancer-related lymphedemacancer survivorshipmedical devicequality of life

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Plastic Surgery, The Ohio State University Medical Center, Columbus, Ohio, USA.

Zitieren

APA

Rockson, S. G., & Skoracki, R. (2023). Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial. Lymphatic Research and Biology, 21(6), 581-584. https://doi.org/10.1089/lrb.2022.0085

Vancouver

Rockson SG, Skoracki R. Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial. Lymphatic Research and Biology. 2023;21(6):581-584. doi:10.1089/lrb.2022.0085

BibTeX
@article{Rockson2023,
  author = {Rockson, Stanley G and Skoracki, Roman},
  title = {Effectiveness of a Nonpneumatic Active Compression Device in Older Adults with Breast Cancer-Related Lymphedema: A Subanalysis of a Randomized Crossover Trial},
  journal = {Lymphatic Research and Biology},
  year = {2023},
  volume = {21},
  number = {6},
  pages = {581--584},
  doi = {10.1089/lrb.2022.0085}
}
Kostenlos starten →